The GluN2B subunits of the NMDAR play an important role in psychiatric and neurological diseases, thus the development of diagnostic and therapeutic agents targeting this receptor will be valuable for the elucidation of its involvement in diseases. This evidence concerns the gene GRIN2B and nervous system disorder.